The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot phase II study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma.
 
Lauren P. Cobb
No Relationships to Disclose
 
Joseph Davis
No Relationships to Disclose
 
Sara Hull
No Relationships to Disclose
 
David J. Vining
Leadership - VisionSR
Stock and Other Ownership Interests - VisionSR
Patents, Royalties, Other Intellectual Property - I receive royalties from Bracco Diagnostics for virtual colonoscopy-related products.
 
Bryan M. Fellman
No Relationships to Disclose
 
Ying Yuan
Honoraria - Ono Pharmaceutical
Consulting or Advisory Role - Abbvie; Amgen; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene/Juno; MicuRx Pharmaceuticals; SERVIER; Starpax Medical; Vertex
 
Shannon Neville Westin
Consulting or Advisory Role - Agenus; AstraZeneca; BioAscent; Clovis Oncology; Curio Science; Curio Science; Eisai; EQRX; Genentech; Gerson Lehrman Group; GlaxoSmithKline; Immunogen; Lilly; Medscape; Merck; Mereo BioPharma; Mersana; OncLive; Roche; Targeted Oncology; Vaniam Group; Vincerx Pharma; Zentalis
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bio-Path Holdings, Inc (Inst); Clovis Oncology (Inst); Cotinga Pharmaceuticals (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Mereo BioPharma (Inst); Novartis (Inst); OncXerna Therapeutics (Inst); Roche/Genentech (Inst)
 
Jolyn Sharpe Taylor
No Relationships to Disclose
 
Michael W. Bevers
No Relationships to Disclose
 
Aaron Shafer
No Relationships to Disclose
 
Nicole D. Fleming
Consulting or Advisory Role - GlaxoSmithKline; Immunogen; Pfizer; Tesaro
 
Karen H. Lu
No Relationships to Disclose
 
David Marc Gershenson
Stock and Other Ownership Interests - Bristol-Myers Squibb; Johnson & Johnson
Consulting or Advisory Role - Genentech; Onconova Therapeutics; SpringWorks Therapeutics
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Elsevier as book editor; Royalties from UpToDate for authorship
 
Amir A. Jazaeri
Stock and Other Ownership Interests - Avenge Bio
Honoraria - Gerson Lehrman Group; Guidepoint Global; Mosaic Research Management
Consulting or Advisory Role - Agenus; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; integrity Continuing Education; Iovance Biotherapeutics; Macrogenics; NuProbe; twoXAR
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); immatics (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); ZIOPHARM Oncology (Inst)